Novo Integrated Sciences Research and Development Expenses 2012-2024 | NVOS

Novo Integrated Sciences research and development expenses from 2012 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Novo Integrated Sciences Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2016 $
2015 $
2014 $
2013 $
2012 $
2012 $0
2011 $0
2011 $
Novo Integrated Sciences Quarterly Research and Development Expenses
(Millions of US $)
2024-02-29
2023-11-30
2023-08-31
2023-05-31
2023-02-28
2022-11-30
2022-08-31
2022-05-31
2022-02-28
2021-11-30
2021-08-31
2021-05-31
2021-02-28
2020-11-30
2020-08-31
2020-05-31
2020-02-29
2019-11-30
2019-08-31
2019-05-31
2019-02-28
2018-11-30
2018-08-31
2018-05-31
2018-02-28
2017-11-30
2017-08-31
2017-05-31
2017-03-31
2017-02-28
2016-12-31
2016-11-30
2016-09-30
2016-06-30
2016-05-31
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29 $0
2011-12-31
2011-11-30 $0
2011-09-30
2011-08-31 $0
2011-06-30 $0
2011-05-31
2011-03-31 $0
2011-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.010B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.403B 10.53
Quest Diagnostics (DGX) United States $15.823B 16.35
DaVita (DVA) United States $11.969B 14.87
Chemed (CHE) United States $8.605B 26.67
Encompass Health (EHC) United States $8.603B 22.02
Elanco Animal Health (ELAN) United States $8.391B 21.77
Option Care Health (OPCH) United States $5.187B 19.63
RadNet (RDNT) United States $4.254B 88.58
Amedisys (AMED) United States $3.103B 21.98
LifeStance Health (LFST) United States $2.817B 0.00
Astrana Health (ASTH) United States $2.304B 31.16
Addus HomeCare (ADUS) United States $1.805B 25.83
U.S Physical Therapy (USPH) United States $1.601B 42.84
Pennant (PNTG) United States $0.673B 35.57
Aveanna Healthcare Holdings (AVAH) United States $0.510B 0.00
Atai Life Sciences (ATAI) Germany $0.311B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00